Kelun-Biotech Receives a Clinical Trial Notice for Its First Dual-payload ADC SKB565

Kelun-Biotech Receives a Clinical Trial Notice for Its First Dual-payload ADC SKB565

CHENGDU, China, July 27, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) today announced that it has received a clinical trial notice from the Center for Drug Evaluation (CDE) of the...

menu
menu